Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0002064832-25-000048

Chief Business Officer gave up 498 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Luu Brendan · Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-12-01 Shares withheld for taxes : show line 1 in the form −498 $14.12 $7,032 39,723 D
Loading xslF345X05/form4.xml…